The global Sepsis Biomarkers market was valued at US$ 579 million in 2023 and is anticipated to reach US$ 700.6 million by 2030, witnessing a CAGR of 2.8% during the forecast period 2024-2030.

Sepsis Biomarkers Market

Sepsis is an unusual systemic reaction to what is sometimes an otherwise ordinary infection, and it probably represents a pattern of response by the immune system to injury.

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

This report aims to provide a comprehensive presentation of the global market for Sepsis Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sepsis Biomarkers.

Report Scope

The Sepsis Biomarkers market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Sepsis Biomarkers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Sepsis Biomarkers companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Sepsis Biomarkers Market Report

Report Metric	Details
Report Name	Sepsis Biomarkers Market
Accounted market size in 2023	US$ 579 million
Forecasted market size in 2030	US$ 700.6 million
CAGR	2.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Blood Biomarkers Urine Biomarkers
Segment by Application	Diagnostics Drug Discovery Personalized Medicine Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott, GenMark Diagnostics, HiMedia Laboratories, Immunexpress, Abionic, T2 Biosystems
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Sepsis Biomarkers companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Sepsis Biomarkers Market growing?

Ans: The Sepsis Biomarkers Market witnessing a CAGR of 2.8% during the forecast period 2024-2030.

What is the Sepsis Biomarkers Market size in 2030?

Ans: The Sepsis Biomarkers Market size in 2030 will be US$ 700.6 million.

Who are the main players in the Sepsis Biomarkers Market report?

Ans: The main players in the Sepsis Biomarkers Market are Thermo Fisher Scientific, Merck, Bio-Rad Laboratories, QIAGEN, Roche, Danaher Corporation, Siemens Healthcare, Abbott, GenMark Diagnostics, HiMedia Laboratories, Immunexpress, Abionic, T2 Biosystems

What are the Application segmentation covered in the Sepsis Biomarkers Market report?

Ans: The Applications covered in the Sepsis Biomarkers Market report are Diagnostics, Drug Discovery, Personalized Medicine, Others

What are the Type segmentation covered in the Sepsis Biomarkers Market report?

Ans: The Types covered in the Sepsis Biomarkers Market report are Blood Biomarkers, Urine Biomarkers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sepsis Biomarkers Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Blood Biomarkers

1.2.3 Urine Biomarkers

1.3 Market by Application

1.3.1 Global Sepsis Biomarkers Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Diagnostics

1.3.3 Drug Discovery

1.3.4 Personalized Medicine

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Sepsis Biomarkers Market Perspective (2019-2030)

2.2 Sepsis Biomarkers Growth Trends by Region

2.2.1 Global Sepsis Biomarkers Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Sepsis Biomarkers Historic Market Size by Region (2019-2024)

2.2.3 Sepsis Biomarkers Forecasted Market Size by Region (2025-2030)

2.3 Sepsis Biomarkers Market Dynamics

2.3.1 Sepsis Biomarkers Industry Trends

2.3.2 Sepsis Biomarkers Market Drivers

2.3.3 Sepsis Biomarkers Market Challenges

2.3.4 Sepsis Biomarkers Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sepsis Biomarkers Players by Revenue

3.1.1 Global Top Sepsis Biomarkers Players by Revenue (2019-2024)

3.1.2 Global Sepsis Biomarkers Revenue Market Share by Players (2019-2024)

3.2 Global Sepsis Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Sepsis Biomarkers Revenue

3.4 Global Sepsis Biomarkers Market Concentration Ratio

3.4.1 Global Sepsis Biomarkers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sepsis Biomarkers Revenue in 2023

3.5 Sepsis Biomarkers Key Players Head office and Area Served

3.6 Key Players Sepsis Biomarkers Product Solution and Service

3.7 Date of Enter into Sepsis Biomarkers Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Sepsis Biomarkers Breakdown Data by Type

4.1 Global Sepsis Biomarkers Historic Market Size by Type (2019-2024)

4.2 Global Sepsis Biomarkers Forecasted Market Size by Type (2025-2030)

5 Sepsis Biomarkers Breakdown Data by Application

5.1 Global Sepsis Biomarkers Historic Market Size by Application (2019-2024)

5.2 Global Sepsis Biomarkers Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Sepsis Biomarkers Market Size (2019-2030)

6.2 North America Sepsis Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Sepsis Biomarkers Market Size by Country (2019-2024)

6.4 North America Sepsis Biomarkers Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Sepsis Biomarkers Market Size (2019-2030)

7.2 Europe Sepsis Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Sepsis Biomarkers Market Size by Country (2019-2024)

7.4 Europe Sepsis Biomarkers Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sepsis Biomarkers Market Size (2019-2030)

8.2 Asia-Pacific Sepsis Biomarkers Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Sepsis Biomarkers Market Size by Region (2019-2024)

8.4 Asia-Pacific Sepsis Biomarkers Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Sepsis Biomarkers Market Size (2019-2030)

9.2 Latin America Sepsis Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Sepsis Biomarkers Market Size by Country (2019-2024)

9.4 Latin America Sepsis Biomarkers Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sepsis Biomarkers Market Size (2019-2030)

10.2 Middle East & Africa Sepsis Biomarkers Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Sepsis Biomarkers Market Size by Country (2019-2024)

10.4 Middle East & Africa Sepsis Biomarkers Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Detail

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Sepsis Biomarkers Introduction

11.1.4 Thermo Fisher Scientific Revenue in Sepsis Biomarkers Business (2019-2024)

11.1.5 Thermo Fisher Scientific Recent Development

11.2 Merck

11.2.1 Merck Company Detail

11.2.2 Merck Business Overview

11.2.3 Merck Sepsis Biomarkers Introduction

11.2.4 Merck Revenue in Sepsis Biomarkers Business (2019-2024)

11.2.5 Merck Recent Development

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Detail

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Sepsis Biomarkers Introduction

11.3.4 Bio-Rad Laboratories Revenue in Sepsis Biomarkers Business (2019-2024)

11.3.5 Bio-Rad Laboratories Recent Development

11.4 QIAGEN

11.4.1 QIAGEN Company Detail

11.4.2 QIAGEN Business Overview

11.4.3 QIAGEN Sepsis Biomarkers Introduction

11.4.4 QIAGEN Revenue in Sepsis Biomarkers Business (2019-2024)

11.4.5 QIAGEN Recent Development

11.5 Roche

11.5.1 Roche Company Detail

11.5.2 Roche Business Overview

11.5.3 Roche Sepsis Biomarkers Introduction

11.5.4 Roche Revenue in Sepsis Biomarkers Business (2019-2024)

11.5.5 Roche Recent Development

11.6 Danaher Corporation

11.6.1 Danaher Corporation Company Detail

11.6.2 Danaher Corporation Business Overview

11.6.3 Danaher Corporation Sepsis Biomarkers Introduction

11.6.4 Danaher Corporation Revenue in Sepsis Biomarkers Business (2019-2024)

11.6.5 Danaher Corporation Recent Development

11.7 Siemens Healthcare

11.7.1 Siemens Healthcare Company Detail

11.7.2 Siemens Healthcare Business Overview

11.7.3 Siemens Healthcare Sepsis Biomarkers Introduction

11.7.4 Siemens Healthcare Revenue in Sepsis Biomarkers Business (2019-2024)

11.7.5 Siemens Healthcare Recent Development

11.8 Abbott

11.8.1 Abbott Company Detail

11.8.2 Abbott Business Overview

11.8.3 Abbott Sepsis Biomarkers Introduction

11.8.4 Abbott Revenue in Sepsis Biomarkers Business (2019-2024)

11.8.5 Abbott Recent Development

11.9 GenMark Diagnostics

11.9.1 GenMark Diagnostics Company Detail

11.9.2 GenMark Diagnostics Business Overview

11.9.3 GenMark Diagnostics Sepsis Biomarkers Introduction

11.9.4 GenMark Diagnostics Revenue in Sepsis Biomarkers Business (2019-2024)

11.9.5 GenMark Diagnostics Recent Development

11.10 HiMedia Laboratories

11.10.1 HiMedia Laboratories Company Detail

11.10.2 HiMedia Laboratories Business Overview

11.10.3 HiMedia Laboratories Sepsis Biomarkers Introduction

11.10.4 HiMedia Laboratories Revenue in Sepsis Biomarkers Business (2019-2024)

11.10.5 HiMedia Laboratories Recent Development

11.11 Immunexpress

11.11.1 Immunexpress Company Detail

11.11.2 Immunexpress Business Overview

11.11.3 Immunexpress Sepsis Biomarkers Introduction

11.11.4 Immunexpress Revenue in Sepsis Biomarkers Business (2019-2024)

11.11.5 Immunexpress Recent Development

11.12 Abionic

11.12.1 Abionic Company Detail

11.12.2 Abionic Business Overview

11.12.3 Abionic Sepsis Biomarkers Introduction

11.12.4 Abionic Revenue in Sepsis Biomarkers Business (2019-2024)

11.12.5 Abionic Recent Development

11.13 T2 Biosystems

11.13.1 T2 Biosystems Company Detail

11.13.2 T2 Biosystems Business Overview

11.13.3 T2 Biosystems Sepsis Biomarkers Introduction

11.13.4 T2 Biosystems Revenue in Sepsis Biomarkers Business (2019-2024)

11.13.5 T2 Biosystems Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Sepsis Biomarkers Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Blood Biomarkers

Table 3. Key Players of Urine Biomarkers

Table 4. Global Sepsis Biomarkers Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Sepsis Biomarkers Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Sepsis Biomarkers Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Sepsis Biomarkers Market Share by Region (2019-2024)

Table 8. Global Sepsis Biomarkers Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Sepsis Biomarkers Market Share by Region (2025-2030)

Table 10. Sepsis Biomarkers Market Trends

Table 11. Sepsis Biomarkers Market Drivers

Table 12. Sepsis Biomarkers Market Challenges

Table 13. Sepsis Biomarkers Market Restraints

Table 14. Global Sepsis Biomarkers Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Sepsis Biomarkers Market Share by Players (2019-2024)

Table 16. Global Top Sepsis Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Biomarkers as of 2023)

Table 17. Ranking of Global Top Sepsis Biomarkers Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Sepsis Biomarkers Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Sepsis Biomarkers Product Solution and Service

Table 21. Date of Enter into Sepsis Biomarkers Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Sepsis Biomarkers Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Sepsis Biomarkers Revenue Market Share by Type (2019-2024)

Table 25. Global Sepsis Biomarkers Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Sepsis Biomarkers Revenue Market Share by Type (2025-2030)

Table 27. Global Sepsis Biomarkers Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Sepsis Biomarkers Revenue Market Share by Application (2019-2024)

Table 29. Global Sepsis Biomarkers Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Sepsis Biomarkers Revenue Market Share by Application (2025-2030)

Table 31. North America Sepsis Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Sepsis Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Sepsis Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Sepsis Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Sepsis Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Sepsis Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Sepsis Biomarkers Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Sepsis Biomarkers Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Sepsis Biomarkers Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Sepsis Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Sepsis Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Sepsis Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Sepsis Biomarkers Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Sepsis Biomarkers Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Sepsis Biomarkers Market Size by Country (2025-2030) & (US$ Million)

Table 46. Thermo Fisher Scientific Company Detail

Table 47. Thermo Fisher Scientific Business Overview

Table 48. Thermo Fisher Scientific Sepsis Biomarkers Product

Table 49. Thermo Fisher Scientific Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 50. Thermo Fisher Scientific Recent Development

Table 51. Merck Company Detail

Table 52. Merck Business Overview

Table 53. Merck Sepsis Biomarkers Product

Table 54. Merck Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 55. Merck Recent Development

Table 56. Bio-Rad Laboratories Company Detail

Table 57. Bio-Rad Laboratories Business Overview

Table 58. Bio-Rad Laboratories Sepsis Biomarkers Product

Table 59. Bio-Rad Laboratories Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 60. Bio-Rad Laboratories Recent Development

Table 61. QIAGEN Company Detail

Table 62. QIAGEN Business Overview

Table 63. QIAGEN Sepsis Biomarkers Product

Table 64. QIAGEN Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 65. QIAGEN Recent Development

Table 66. Roche Company Detail

Table 67. Roche Business Overview

Table 68. Roche Sepsis Biomarkers Product

Table 69. Roche Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 70. Roche Recent Development

Table 71. Danaher Corporation Company Detail

Table 72. Danaher Corporation Business Overview

Table 73. Danaher Corporation Sepsis Biomarkers Product

Table 74. Danaher Corporation Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 75. Danaher Corporation Recent Development

Table 76. Siemens Healthcare Company Detail

Table 77. Siemens Healthcare Business Overview

Table 78. Siemens Healthcare Sepsis Biomarkers Product

Table 79. Siemens Healthcare Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 80. Siemens Healthcare Recent Development

Table 81. Abbott Company Detail

Table 82. Abbott Business Overview

Table 83. Abbott Sepsis Biomarkers Product

Table 84. Abbott Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 85. Abbott Recent Development

Table 86. GenMark Diagnostics Company Detail

Table 87. GenMark Diagnostics Business Overview

Table 88. GenMark Diagnostics Sepsis Biomarkers Product

Table 89. GenMark Diagnostics Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 90. GenMark Diagnostics Recent Development

Table 91. HiMedia Laboratories Company Detail

Table 92. HiMedia Laboratories Business Overview

Table 93. HiMedia Laboratories Sepsis Biomarkers Product

Table 94. HiMedia Laboratories Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 95. HiMedia Laboratories Recent Development

Table 96. Immunexpress Company Detail

Table 97. Immunexpress Business Overview

Table 98. Immunexpress Sepsis Biomarkers Product

Table 99. Immunexpress Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 100. Immunexpress Recent Development

Table 101. Abionic Company Detail

Table 102. Abionic Business Overview

Table 103. Abionic Sepsis Biomarkers Product

Table 104. Abionic Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 105. Abionic Recent Development

Table 106. T2 Biosystems Company Detail

Table 107. T2 Biosystems Business Overview

Table 108. T2 Biosystems Sepsis Biomarkers Product

Table 109. T2 Biosystems Revenue in Sepsis Biomarkers Business (2019-2024) & (US$ Million)

Table 110. T2 Biosystems Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Sepsis Biomarkers Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Sepsis Biomarkers Market Share by Type: 2023 VS 2030

Figure 3. Blood Biomarkers Features

Figure 4. Urine Biomarkers Features

Figure 5. Global Sepsis Biomarkers Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global Sepsis Biomarkers Market Share by Application: 2023 VS 2030

Figure 7. Diagnostics Case Studies

Figure 8. Drug Discovery Case Studies

Figure 9. Personalized Medicine Case Studies

Figure 10. Others Case Studies

Figure 11. Sepsis Biomarkers Report Years Considered

Figure 12. Global Sepsis Biomarkers Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global Sepsis Biomarkers Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Sepsis Biomarkers Market Share by Region: 2023 VS 2030

Figure 15. Global Sepsis Biomarkers Market Share by Players in 2023

Figure 16. Global Top Sepsis Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Biomarkers as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by Sepsis Biomarkers Revenue in 2023

Figure 18. North America Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America Sepsis Biomarkers Market Share by Country (2019-2030)

Figure 20. United States Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Sepsis Biomarkers Market Share by Country (2019-2030)

Figure 24. Germany Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Sepsis Biomarkers Market Share by Region (2019-2030)

Figure 32. China Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Sepsis Biomarkers Market Share by Country (2019-2030)

Figure 40. Mexico Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Sepsis Biomarkers Market Share by Country (2019-2030)

Figure 44. Turkey Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia Sepsis Biomarkers Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 47. Merck Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 48. Bio-Rad Laboratories Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 49. QIAGEN Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 50. Roche Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 51. Danaher Corporation Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 52. Siemens Healthcare Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 53. Abbott Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 54. GenMark Diagnostics Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 55. HiMedia Laboratories Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 56. Immunexpress Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 57. Abionic Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 58. T2 Biosystems Revenue Growth Rate in Sepsis Biomarkers Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions